Oscar Health, Inc. (OSCR)

Oscar Health Stock Forecast

Stock Price Forecast

The 7 analysts that cover Oscar Health stock have a consensus rating of "Sell" and an average price target of $12.79, which forecasts a -15.63% decrease in the stock price over the next year. The lowest target is $10 and the highest is $18.

Price Target: $12.79 (-15.63%)

Analyst Consensus: Sell

Target	Low	Average	Median	High
Price	$10	$12.79	$12	$18
Change	-34.04%	-15.63%	-20.84%	+18.73%

Analyst Ratings

The average analyst rating for Oscar Health stock is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.

Recommendation Trends

Rating	Mar '25	Apr '25	May '25	Jun '25	Jul '25	Aug '25
Strong Buy	0	0	0	0	0	0
Buy	3	3	3	1	1	1
Hold	3	3	3	2	1	1
Sell	2	2	2	2	4	4
Strong Sell	0	0	0	0	1	1
Total	8	8	8	5	7	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Michael Ha Baird	Baird	Buy → Hold Downgrades $28 → $14	Buy → Hold	Downgrades	$28 → $14	-7.65%	Jul 25, 2025
Andrew Mok Barclays	Barclays	Sell Maintains $17 → $11	Sell	Maintains	$17 → $11	-27.44%	Jul 23, 2025
Jonathan Yong UBS	UBS	Hold → Strong Sell Downgrades $15 → $11	Hold → Strong Sell	Downgrades	$15 → $11	-27.44%	Jul 15, 2025
Stephen Baxter Wells Fargo	Wells Fargo	Hold → Sell Downgrades $16 → $10	Hold → Sell	Downgrades	$16 → $10	-34.04%	Jul 11, 2025
Andrew Mok Barclays	Barclays	Sell Initiates $17	Sell	Initiates	$17	+12.14%	Jul 2, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

12.03B

Increased by 31.12%

from 9.18B

Revenue Next Year

11.31B

Decreased by -6.01%

from 12.03B

EPS This Year

0.70

Increased by 603.80%

from 0.10

EPS Next Year

0.90

Increased by 28.36%

from 0.70

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	390.99M	1.89B	3.96B	5.86B	9.18B	12.03B	11.31B	13.09B
Revenue Growth	-17.79%	384.43%	109.27%	47.92%	56.54%	31.12%	-6.01%	15.68%
EPS	-14.16	-3.20	-2.85	-1.22	0.10	0.70	0.90	1.67
EPS Growth	-	-	-	-	-	603.80%	28.36%	85.16%
Forward PE	-	-	-	-	-	21.54	16.78	9.06
No. Analysts	-	-	-	-	-	11	11	9

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	12.7B	13.3B	14.9B
Avg	12.0B	11.3B	13.1B
Low	11.0B	10.0B	9.6B

Revenue Growth

Revenue Growth	2025	2026	2027
High	38.6%	10.7%	32.1%
Avg	31.1%	-6.0%	15.7%
Low	20.1%	-16.9%	-14.8%

EPS Forecast

EPS	2025	2026	2027
High	0.92	1.97	2.36
Avg	0.70	0.90	1.67
Low	0.58	0.09	0.54

EPS Growth

EPS Growth	2025	2026	2027
High	824.0%	180.5%	161.5%
Avg	603.8%	28.4%	85.2%
Low	478.2%	-87.5%	-40.3%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.